Duality Advisers, LP Nevro Corp Transaction History

Duality Advisers, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$22.62 - $39.32 $191,274 - $332,489	8,456 New	8,456 $214,000
Q2 2022 Aug 08, 2022	SELL	$40.85 - $77.67 $423,165 - $804,583	-10,359 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$59.95 - $92.06 $58,271 - $89,482	972 Added 10.35%	10,359 $749,000
Q4 2021 Feb 02, 2022	SELL	$81.07 - $121.29 $446,776 - $668,429	-5,511 Reduced 36.99%	9,387 $761,000
Q3 2021 Nov 08, 2021	BUY	$101.99 - $166.36 $1.52 Million - $2.48 Million	14,898 New	14,898 $1.73 Million
Q2 2021 Aug 09, 2021	SELL	$141.6 - $179.06 $2.63 Million - $3.33 Million	-18,594 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $2.26 Million - $3.11 Million	17,054 Added 1107.4%	18,594 $2.59 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $212,781 - $283,883	1,540 New	1,540 $267,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.